ANP Technologies® Inc receives Innovators Award from Delaware Bioscience Association
Newark, DE – April 20, 2018
ANP Technologies® Inc received an Innovators Award and was featured as one of the Top Innovators at the “Igniting Innovation 2018 Gala” held at DuPont Country Club on April 19, 2018. Over 600 industrial and academic experts participated this annual event organized by the Delaware at the Delaware Bioscience Association.
Led by its CEO Dr. Ray Yin, ANP Technologies® Inc. has successfully developed and fielded the NIDS® (Nano Intelligent Detection System) Rapid Handheld Biothreat Detection System for the US Military. In addition, the NIDS® technology has also been widely used for the immunogenicity testing of various biological drugs by the biotech/pharma industry.
Thus far, the ANP team has won the 2010 American Association of Pharmaceutical Scientists (AAPS) Excellence in Ligand Binding Assay Annual Award and 2011 National Tibbetts Awards for Innovated R&D for the US Military. The NIDS® biothreat detection system is currently fielded/used by the US Military (Army, Navy, Air Force and Marines), Army and Air National Guards in all 50 States, as well as FEMA/DHS and various first responders.
ANP and its partners also have several other drugs in the pipeline including an antibody cocktail against the Ebola virus and chemotherapy drugs, as well as several other immune-oncology therapies and mRNA-based vaccines.
About ANP Technologies, Inc.
ANP Technologies, Inc. is a world leader in developing and commercializing various Nano-biotechnology-based products for applications in Nano-therapeutics, immunogenicity testing, chemical and biological defense, medical diagnostics, and food safety testing.